Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics-Reference-Cited by-同舟云学术

Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics

Published:2018-01-09 Issue:1 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Shahin Mohamed H.¹,Gong Yan¹,Frye Reginald F.¹,Rotroff Daniel M.²,Beitelshees Amber L.³,Baillie Rebecca A.⁴,Chapman Arlene B.⁵,Gums John G.¹,Turner Stephen T.⁶,Boerwinkle Eric⁷,Motsinger‐Reif Alison²,Fiehn Oliver⁸⁹,Cooper‐DeHoff Rhonda M.¹,Han Xianlin¹⁰,Kaddurah‐Daouk Rima¹¹,Johnson Julie A.¹

Affiliation:

1. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL

2. Bioinformatics Research Center, North Carolina State University, Raleigh, NC

3. Department of Medicine, University of Maryland, Baltimore, MD

4. Rosa & Co LLC, San Carlos, CA

5. Department of Medicine, University of Chicago, IL

6. College of Medicine, Mayo Clinic, Rochester, MN

7. Human Genetics Center and Institute for Molecular Medicine, University of Texas Health Science Center, Houston, TX

8. Genome Center, University of California at Davis, CA

9. Biochemistry Department, King Abdulaziz University, Jeddah, Saudi‐Arabia

10. Sanford‐Burnham Medical Research Institute, Orlando, FL

11. Department of Psychiatry and Behavioural Sciences and Department of Medicine, Duke University, Durham, NC